prednisone has been researched along with Central Nervous System Lupus in 12 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute cerebellar ataxia is a rare primary manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE)." | 2.72 | Cerebellar ataxia as a primary manifestation of neuropsychiatric systemic lupus erythematosus. ( Fernandez, MLL; Reyes, NGD; Sy, MCC; Zamora, GT, 2021) |
| "Prednisone treatment (3 mg/kg from 8 weeks of age) relieved the decrease of NAA but further increased the accumulation of pyruvate in the frontal cortex, additionally affected eight enriched pathways in the hypothalamus, and led to significant imbalances between the excitation and inhibition in both the frontal cortex and hypothalamus." | 1.56 | Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice. ( Li, S; Lu, F; Lu, H; Wang, S; Wen, C; Wu, D; Xie, M; Xie, Z; Xu, ZH; Zhou, J, 2020) |
| "Childhood-onset systemic lupus erythematosus (SLE) is a severe, lifelong, multisystem autoimmune disease." | 1.51 | Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. ( Bijl, M; Bultink, IEM; de Leeuw, K; Dolhain, RJEM; Fritsch-Stork, R; Groot, N; Kamphuis, S; Shaikhani, D; Teng, YKO; Zirkzee, E, 2019) |
| "Objective Neuropsychiatric systemic lupus erythematosus (NPSLE) is a manifestation of systemic lupus erythematosus (SLE)." | 1.48 | Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. ( Fang, H; Lan, L; Lv, J; Qu, Y; Zhang, Q, 2018) |
| "Even with proper immunosuppressive treatment, SLE can relapse." | 1.37 | Lupus relapse presented as frosted branch retinal angiitis: case report. ( Arellanes-Garcia, L; Cornejo-Ballesteros, H; Hernandez-Da Mota, SE; Melgoza-del-Angel, C; Recillas-Gispert, C; Sanchez-Gonzalez, R; Teran-Estrada, L, 2011) |
| "Maintenance therapy of severe pediatric systemic lupus erythematosus (SLE) usually consists of azathioprine and prednisone ." | 1.35 | Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus. ( Amann, K; Benz, K; Dittrich, K; Dötsch, J; Ross, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, J | 2 |
| Lu, F | 2 |
| Li, S | 2 |
| Xie, M | 2 |
| Lu, H | 2 |
| Xie, Z | 1 |
| Wu, D | 1 |
| Wang, S | 2 |
| Wen, C | 2 |
| Xu, ZH | 1 |
| Sy, MCC | 1 |
| Reyes, NGD | 1 |
| Zamora, GT | 1 |
| Fernandez, MLL | 1 |
| Fang, H | 1 |
| Lan, L | 1 |
| Qu, Y | 1 |
| Zhang, Q | 1 |
| Lv, J | 1 |
| Groot, N | 1 |
| Shaikhani, D | 1 |
| Teng, YKO | 1 |
| de Leeuw, K | 1 |
| Bijl, M | 1 |
| Dolhain, RJEM | 1 |
| Zirkzee, E | 1 |
| Fritsch-Stork, R | 1 |
| Bultink, IEM | 1 |
| Kamphuis, S | 1 |
| Zu, Y | 1 |
| Yu, J | 1 |
| Ruan, Y | 1 |
| Xu, Z | 1 |
| Ataia, I | 1 |
| Casaulta, C | 1 |
| von Vigier, RO | 1 |
| Pfammatter, JP | 1 |
| Brekenfeld, C | 1 |
| Sauvain, MJ | 1 |
| Steinlin, M | 1 |
| Bhagavati, S | 1 |
| Choi, J | 1 |
| Descloux, E | 1 |
| Durieu, I | 1 |
| Cochat, P | 1 |
| Vital-Durand, D | 1 |
| Ninet, J | 1 |
| Fabien, N | 1 |
| Cimaz, R | 1 |
| Geara, AS | 1 |
| Torbey, E | 1 |
| El-imad, B | 1 |
| Dittrich, K | 1 |
| Ross, S | 1 |
| Benz, K | 1 |
| Amann, K | 1 |
| Dötsch, J | 1 |
| Hernandez-Da Mota, SE | 1 |
| Arellanes-Garcia, L | 1 |
| Recillas-Gispert, C | 1 |
| Cornejo-Ballesteros, H | 1 |
| Melgoza-del-Angel, C | 1 |
| Teran-Estrada, L | 1 |
| Sanchez-Gonzalez, R | 1 |
| Olfat, MO | 1 |
| Al-Mayouf, SM | 1 |
| Muzaffer, MA | 1 |
1 review available for prednisone and Central Nervous System Lupus
| Article | Year |
|---|---|
Cerebellar ataxia as a primary manifestation of neuropsychiatric systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antimalarials; Cerebellar Ataxia; Female; Gait Analysis; Headache; | 2021 |
11 other studies available for prednisone and Central Nervous System Lupus
| Article | Year |
|---|---|
Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
Topics: Animals; Brain; Disease Models, Animal; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoid | 2020 |
Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Central Nervous System Infection | 2018 |
Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Topics: Adolescent; Adult; Age of Onset; Aged; Antibodies, Antiphospholipid; Antirheumatic Agents; Child; Ch | 2019 |
Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Topics: Animals; Brain; Cardiolipins; Depression; Disease Models, Animal; Female; Glucocorticoids; Lupus Vas | 2019 |
[Vasculitis as a reason of chronic headache].
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Chorea; Cyclophosphamide; Diagnosis, Differential; Drug T | 2008 |
Reversible basal ganglia and amygdala lesions in central nervous system lupus.
Topics: Adolescent; Amygdala; Antirheumatic Agents; Basal Ganglia; Female; Humans; Lupus Vasculitis, Central | 2008 |
Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus.
Topics: Adolescent; Age of Onset; Cause of Death; Child; Female; Humans; Immunosuppressive Agents; Kaplan-Me | 2009 |
Lupus cerebritis after visiting a tanning salon.
Topics: Antibodies, Antinuclear; Anticonvulsants; Beauty Culture; Female; Headache; Humans; Immunosuppressiv | 2009 |
Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Topics: Adolescent; Azathioprine; Child; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy | 2009 |
Lupus relapse presented as frosted branch retinal angiitis: case report.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervou | 2011 |
Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.
Topics: Adolescent; Cerebrovascular Disorders; Child; Child, Preschool; Disease-Free Survival; Electroenceph | 2004 |